StockNews.com Initiates Coverage on Global Cord Blood (NYSE:CO)

Equities researchers at StockNews.com began coverage on shares of Global Cord Blood (NYSE:COGet Free Report) in a report issued on Thursday. The brokerage set a “strong-buy” rating on the medical research company’s stock.

Global Cord Blood Price Performance

CO opened at $1.50 on Thursday. The company has a fifty day moving average price of $1.46 and a 200-day moving average price of $1.34. The firm has a market capitalization of $182.33 million, a P/E ratio of 2.34 and a beta of 0.16. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50.

About Global Cord Blood

(Get Free Report)

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.

Featured Articles

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.